Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerold Bepler

Showing results (91-100 of 156) with videos related to

Pageof 16
Sort By:
Oncotarget|September 22, 2016
Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cellsSanjeevani Arora, Joshua Heyza, Hao Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 13, 2018
Identification and Characterization of Synthetic Viability with ERCC1 Deficiency in Response to Interstrand Crosslinks in Lung CancerJoshua R Heyza, Wen Lei, Donovan Watza, et al.
The Journal of Biological Chemistry|January 14, 2010
A small molecule inhibits Akt through direct binding to Akt and preventing Akt membrane translocationDonghwa Kim, Mei Sun, Lili He, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Physician referral for fertility preservation in oncology patients: a national study of practice behaviorsGwendolyn P Quinn, Susan T Vadaparampil, Ji-Hyun Lee, et al.
The Journal of Biological Chemistry|November 9, 2016
A small molecule inhibits Akt through direct binding to Akt and preventing Akt membrane translocationDonghwa Kim, Mei Sun, Lili He, et al.
Cancer Chemotherapy and Pharmacology|June 1, 2010
Phase I-II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclinesPatrizia Vici, Alessandra Fabi, Giulio Metro, et al.
Cancer Immunology Research|February 26, 2015
Induction of HER2 Immunity in Outbred Domestic Cats by DNA ElectrovaccinationHeather M Gibson, Jesse J Veenstra, Richard Jones, et al.
Patient Education and Counseling|October 23, 2009
Patient-provider communication and perspectives on smoking cessation and relapse in the oncology settingVani Nath Simmons, Erika B Litvin, Riddhi D Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patientsRafael Rosell, Kathleen D Danenberg, Vincente Alberola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancerGeorge Simon, Anupama Sharma, Xueli Li, et al.
Pageof 16

Showing results (91-100 of 156) with videos related to

Sort By:
Pageof 16
Oncotarget|September 22, 2016
Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cellsSanjeevani Arora, Joshua Heyza, Hao Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 13, 2018
Identification and Characterization of Synthetic Viability with ERCC1 Deficiency in Response to Interstrand Crosslinks in Lung CancerJoshua R Heyza, Wen Lei, Donovan Watza, et al.
The Journal of Biological Chemistry|January 14, 2010
A small molecule inhibits Akt through direct binding to Akt and preventing Akt membrane translocationDonghwa Kim, Mei Sun, Lili He, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Physician referral for fertility preservation in oncology patients: a national study of practice behaviorsGwendolyn P Quinn, Susan T Vadaparampil, Ji-Hyun Lee, et al.
The Journal of Biological Chemistry|November 9, 2016
A small molecule inhibits Akt through direct binding to Akt and preventing Akt membrane translocationDonghwa Kim, Mei Sun, Lili He, et al.
Cancer Chemotherapy and Pharmacology|June 1, 2010
Phase I-II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclinesPatrizia Vici, Alessandra Fabi, Giulio Metro, et al.
Cancer Immunology Research|February 26, 2015
Induction of HER2 Immunity in Outbred Domestic Cats by DNA ElectrovaccinationHeather M Gibson, Jesse J Veenstra, Richard Jones, et al.
Patient Education and Counseling|October 23, 2009
Patient-provider communication and perspectives on smoking cessation and relapse in the oncology settingVani Nath Simmons, Erika B Litvin, Riddhi D Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patientsRafael Rosell, Kathleen D Danenberg, Vincente Alberola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancerGeorge Simon, Anupama Sharma, Xueli Li, et al.
Pageof 16